Utility of the brief Patient Health Questionnaire-2 and Generalized Anxiety Disorder-2 screeners for depression and generalized anxiety symptom identification in people with human immunodeficiency virus
Grace Yeeun Lee(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Tracy Agee(Johns Hopkins University), Tarfa Verinumbe(Albert Einstein College of Medicine), J. M. Hsu(Johns Hopkins University), Sharon M. Kelly(University of Glasgow), Heidi E. Hutton(Johns Hopkins University), Janelle Jones(Johns Hopkins University), Maria C. Latimer
Cited by 0
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
|Nature Communications|2014|339
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
|Mycoses|2011|159
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review
|UNC Libraries|2020|111